Favourable results with local injections of botulinum-A toxin in patients with chronic isosorbide dinitrate ointment-resistant anal fissures;Gunstige resultaten van lokale injectie met botuline A toxine bij patiënten met chronische anale fissuren die niet reageren op behandeling met isosorbidedinitraatzalf

Nederlands Tijdschrift voor Geneeskunde

Volumn 150, Issue 27, 2006, Pages 1513-1517

  Witte, M E ^a   Klaase, J M ^a  

^a MEDISCH SPECTRUM TWENTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A; ISOSORBIDE DINITRATE;

ADULT; AGED; ANUS FISSURE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG TOLERANCE; FEMALE; FOLLOW UP; GENERAL ANESTHESIA; HUMAN; MALE; SPINAL ANESTHESIA; TREATMENT OUTCOME;

ADULT; AGED; ANAL CANAL; BOTULINUM TOXIN TYPE A; FEMALE; FISSURE IN ANO; HUMANS; ISOSORBIDE DINITRATE; MALE; MIDDLE AGED; NEUROMUSCULAR AGENTS; NITRIC OXIDE DONORS; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 33746346753     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Lindsey I, Jones OM, Cunningham C, Mortensen NJ. Chronic anal fissure. Br J Surg. 2004;91:270-9.
2. McCallion K, Gardiner KR. Progress in the understanding and treatment of chronic anal fissure. Postgrad Med J. 2001;77:753-8.
3. Lund JN, Binch C, McGrath J, Sparrow RA, Scholefield JH. Topographical distribution of blood supply to the anal canal. Br J Surg. 1999;86:496-8.
4. Schouten WR, Briel JW, Auwerda JJ. Relationship between anal pressure and anodermal blood flow. The vascular pathogenesis of anal fissures. Dis Colon Rectum. 1994;37:664-9.
5. Utzig MJ, Kroesen AJ, Buhr HJ. Concepts in pathogenesis and treatment of chronic anal fissure - a review of the literature. Am J Gastroenterol. 2003;98:968-74.
6. Nielsen MB, Rasmussen OØ, Pedersen JF, Christiansen J. Risk of sfincter damage and anal incontinence after anal dilatation for fissure-in-ano. An endosonographic study. Dis Colon Rectum. 1993;36:677-80.
7. Jost WH. One hundred cases of anal fissure treated with botulin toxin: early and long-term results. Dis Colon Rectum. 1997;40:1029-32.
8. Lindsey I, Jones OM, Cunningham C, George BD, Mortensen NJ. Botulinum toxin as second-line therapy for chronic anal fissure failing 0.2 percent glyceryl trinitrate. Dis Colon Rectum. 2003;46: 361-6.
9. Wiley M, Day P, Rieger N, Stephens J, Moore J. Open vs. closed lateral internal sphincterotomy for idiopathic fissure-in-ano: a prospective, randomized, controlled trial. Dis Colon Rectum. 2004;47:847-52.
10. Nyam DC, Pemberton JH. Long-term results of lateral internal sphincterotomy for chronic anal fissure with particular reference to the incidence of fecal incontinence. Dis Colon Rectum. 1999; 42:1306-10.
11. Carapeti EA, Kamm MA, McDonald PJ, Chadwick SJ, Melville D, Phillips RK. Randomised controlled trial shows that glyceryl trinitrate heals anal fissures, higher doses are not more effective, and there is a high recurrence rate. Gut. 1999144:727-30.
12. Brisinda G, Maria G, Bentivoglio AR, Cassetta E, Gui D, Albanese A. A comparison of injections of botulinum toxin and topical nitroglycerin ointment for the treatment of chronic anal fissure. N Engl J Med. 1999;341:65-9.
13. Scholefield JH, Bock JU, Maria B, Richter HJ, Athanasiadis S, Pröls M, et al. A dose finding study with 0.1%, 0.2%, and 0.4% glyceryl trinitrate ointment in patients with chronic anal fissures. Gut. 2003; 52:264-9.
14. Jonas M, Lund JN, Scholefield JH. Topical 0.2% glyceryl trinitrate ointment for anal fissures: long-term efficacy in routine clinical practice. Colorectal Dis. 2002;4:317-20.
15. Libertiny G, Knight JS, Farouk R. Randomised trial of topical 0.2% glyceryl trinitrate and lateral internal sphincterotomy for the treatment of patients with chronic anal fissure: long-term follow-up. Eur J Surg. 2002;168:418-21.
16. Schouten WR, Briel JW, Auwerda JJA, Boerma MO, Graatsma BH, Wilms EB. Intra-anale applicatie van isosorbidedinitraat bij chronische fissura ani. Ned Tijdschr Geneeskd. 1995;139:1447-9.
17. Werre AJ, Palamba HW, Bilgen EJ, Eggink WF. Isosorbide dinitrate in the treatment of anal fissure: a randomised, prospective, double blind, placebo-controlled trial. Eur J Surg. 2001;167:382-5.
18. Lund JN, Scholefield JH. A randomised, prospective, double-blind, placebo-controlled trial of glyceryl trinitrate ointment in treatment of anal fissure. Lancet. 1997;349:11-4.
19. Jonas M, Neal KR, Abercrombie JF, Scholefield JH. A randomized trial of oral vs. topical diltiazem for chronic anal fissures. Dis Colon Rectum. 2001;44:1074-8.
20. Perrotti P, Bove A, Antropoli C, Molino D, Antropoli M, Balzano A, et al. Topical nifedipine with lidocaine ointment vs. active control for treatment of chronic anal fissure: results of a prospective, randomized, double-blind study. Dis Colon Rectum. 2002;45:1468-75.
21. Kocher HM, Steward M, Leather AJ, Cullen PT. Randomized clinical trial assessing the side-effects of glyceryl-trinitrate and diltiazem hydrochloride in the treatment of chronic anal fissure. Br J Surg. 2002;89:413-7.
22. Bielecki K, Kolodziejczak M. A prospective randomized trial of diltiazem and glyceryltrinitrate ointment in the treatment of chronic anal fissure. Colorectal Dis. 2003;5:256-7.
23. DasGupta R, Franklin I, Pitt J, Dawson PM. Successful treatment of chronic anal fissure with diltiazem gel. Colorectal Dis. 2002;4:20-2.
24. Griffin N, Acheson AG, Jonas M, Scholefield JH. The role of topical diltiazem in the treatment of chronic anal fissures that have failed glyceryl trinitrate therapy. Colorectal Dis. 2002;4:430-5.
25. Jones OM, Moore JA, Brading AF, Mortensen NJ. Botulinum toxin injection inhibits myogenic tone and sympathetic nerve function in the porcine internal anal sphincter. Colorectal Dis. 2003;5:552-7.
26. Jost WH, Schimrigk K. Therapy of anal fissure using botulin toxin. Dis Colon Rectum. 1994;37:1321-4.
27. Maria G, Cassetta E, Gui D, Brisinda G, Bentivoglio AR, Albanese A. A comparison of botulinum toxin and saline for the treatment of chronic anal fissure. N Engl J Med. 1998;338:217-20.
28. Maria G, Brisinda G, Bentivoglio AR, Cassetta E, Gui D, Albanese A. Influence of botulinum toxin site of injections on healing rate in patients with chronic anal fissure. Am J Surg. 2000;179:46-50.
29. Trzciński R, Dziki A, Tchórzewski M. Injections of botulinum A toxin for the treatment of anal fissures. Eur J Surg. 2002;168:720-3.
30. Jost WH, Schanne S, Mlitz H, Schimrigk K. Perianal thrombosis following injection therapy into the external anal sphincter using botulin toxin. Dis Colon Rectum. 1995;38:781.
31. Minguez M, Herreros B, Espi A, Garcia-Granero E, Sanchiz V, Mora F, et al. Long-term follow-up (42 months) of chronic anal fissure after healing with botulinum toxin. Gastroenterology. 2002;123:112-7.
32. Giral A, Memişoǧlu K, Gültekin Y, Ïmeryüz N, Kalayci C, Ulusoy NB, et al. Botulinum toxin injection versus lateral internal sphincterotomy in the treatment of chronic anal fissure: a non-randomized controlled trial. BMC Gastroenterol. 2004;4:7.
33. Zimmerman DD, Delemarre JB, Gosselink MP, Hop WC, Briel JW, Schouten WR. Smoking affects the outcome of transanal mucosal advancement flap repair of trans-sphincteric fistulas. Br J Surg. 2003; 90:351-4.